Acceptability and Feasibility of Medical Abortion Using Mifepristone and Buccal Misoprostol

NACompletedINTERVENTIONAL
Enrollment

1,250

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Abortion, First Trimester
Interventions
DRUG

mifepristone-misoprostol treatment

200 mg mifepristone followed by 800 mcg buccal misoprostol 24-48 hours after the mifepristone.

Trial Locations (11)

Unknown

Center for Family Planning and Sexual Health, Yerevan

Institute of Perinatology, Obstetrics and Gynecology, Yerevan

State Medical University, Yerevan

Family Planning Center, Baku

Scientific Research Institute of Obstetrics and Gynecology, Baku

C.S. Beatriz Velasco Aleman, Mexico City

C.S. Santa Catarina, Mexico City

H.G. Enrique Cabrera, Mexico City

H.M.I Inguaran, Mexico City

00956

Clinica de Planificacion Familiar, Lomas Verdes, Bayamon

00921

Woman's Metropolitan Center, San Juan

All Listed Sponsors
lead

Gynuity Health Projects

OTHER

NCT00386282 - Acceptability and Feasibility of Medical Abortion Using Mifepristone and Buccal Misoprostol | Biotech Hunter | Biotech Hunter